In Silico Modeling of Changes to Ventricular Myocyte Action Potential Morphology Caused by Pharmacological Agents (original) (raw)

In silico modeling has been employed to explore changes in the action potential morphology of ventricular myocytes induced by various pharmacological agents. This study investigates the computational approaches used to simulate these morphological alterations, providing insights into their physiological relevance and potential applications in drug discovery and safety assessment for cardiac considerations. The findings reveal a complex interaction between pharmacological agents and myocyte electrical activity, emphasizing the importance of such models in understanding drug effects on cardiac function.